Timothy J. Harris v. Mary Ellen Harris

Court of Chancery of Delaware·Decided January 23, 2023·No. C.A. No. 2019-0736-JTL·Published

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE

TIMOTHY J. HARRIS, et al. ) ) Plaintiffs, ) ) v. ) C.A. No. 2019-0736-JTL ) MARY ELLEN HARRIS, et al., ) ) Defendants. )

MEMORANDUM OPINION

Date Submitted: November 9, 2022 Date Decided: January 23, 2023

Joel Friedlander, Christopher M. Foulds, David Hahn, FRIEDLANDER & GORRIS, P.A., Wilmington, Delaware; Counsel for Petitioner/Plaintiff Timothy J. Harris.

S. Michael Sirkin, R. Garrett Rice, ROSS ARONSTAM & MORITZ LLP, Wilmington Delaware; Gregory Lomax, LAULETTA BIRNBAUM, Sewell, New Jersey; Jill Guldin, FISHER BROYLES, LLP, Princeton, New Jersey; Counsel for Kristen C. Harris and Megan Harris Loewenberg.

David A. Jenkins, Julie M. O’Dell, SMITH, KATZENSTEIN & JENKINS LLP; Wilmington, Delaware; Counsel for Mary Ellen Harris.

Steven L. Caponi, Matthew B. Goeller, Megan E. O’Connor, K&L GATES LLP, Wilmington, Delaware; Counsel for Mary Ellen Harris, Paul Petigrow, and Michael Schwager.

Kurt M. Heyman, Patricia L. Enerio, Gillian L. Andrews, HEYMAN ENERIO GATTUSO & HIRZEL LLP, Wilmington, Delaware; Counsel for Royce Management, Inc., Judith Lolli, and Charles Grinnell.

John L. Reed, Ronald N. Brown, III, Peter H. Kyle, Kelly L. Freund, DLA PIPER LLP (US), Wilmington, Delaware; Neal J. Levitsky, E. Chaney Hall, FOX ROTHSCHILD LLP, Wilmington, Delaware; Emily A. Kaller, GREENBAUM, ROWE, SMITH & DAVIS LLP, Woodbridge, New Jersey; Counsel for Harris FRC Corporation. William M. Kelleher, Phillip A. Giordano, Madeline Silverman, GORDON, FOURNARIS & MAMMARELLA, P.A., Wilmington, Delaware; Counsel for The Mary Ellen Harris 2011 Grantor Retained Annuity Trust.

LASTER, V.C. Five of the six defendants have asked the court to dismiss this action under the

doctrine of forum non conveniens. There is no earlier-filed action elsewhere involving

substantially the same parties, addressing substantially the same subject matter, and

pending in a court capable of providing substantial justice, so the defendants have the

burden of showing that they would face overwhelming hardship from litigating in

Delaware. The defendants have not met that standard. The motion is denied.

I. FACTUAL BACKGROUND

The facts are drawn from the plaintiffs’ Verified Supplemental and Third

Amended Complaint (the “Complaint”) and the documents that it incorporates by 1 reference. At this procedural stage, the plaintiffs are entitled to have the court credit

their allegations and draw all reasonable inferences in their favor.

A. The Company

Before May 2016, Harris FRC Corporation (the “Company”) was a New Jersey

corporation. From May 2016 until May 2019, the Company was a Delaware corporation.

Since May 2019, the Company has been a New Jersey corporation. It is and always has

been a family-held entity. Currently, its only stockholders are Mary Ellen Harris, her five

adult children (the “Siblings”), and various trusts created for their benefit.

1 Citations in the form “Ex. __” refer to documents attached to the Affidavit of Christopher M. Foulds, which collects certain documents that are incorporated by reference in the Complaint. Dkt. 467. The family patriarch, Dr. Robert M. Harris, Sr. founded the Company after

securing the patent rights for an epilepsy drug.2 He monetized the patent rights through a

license agreement with a global biopharmaceutical company and formed the Company to

hold the rights and receive the royalty payments. That revenue stream historically

amounted to approximately $100 million per year. The Company’s only significant

function was to collect and distribute the payments. In 2020, the Company sold its patent

rights for $342 million in cash.

The Company has issued 1,000 shares. Originally, Dr. Harris and Mary Ellen

owned all of the shares jointly as tenants by the entirety. In 2002, they transferred 38

shares to each of the Siblings, resulting in each owning a 3.8% interest. In 2011, Dr.

Harris and Mary Ellen each created a grantor retained annuity trust (a “GRAT”) and

funded it with 245 shares. The GRATs had terms of seven years and would expire on

December 31, 2018. At that point, the shares would be distributed to the Siblings.

Through the combination of the 190 shares they received directly and the 490 shares

distributed from the GRATs, the Siblings would receive a total of 680 shares,

representing a controlling 68% interest in the Company.

2 My standard practice is to identify individuals by their last name without honorifics. When individuals share the same last name, my standard practice is to shift to first names. Using first names is confusing because Dr. Robert M. Harris has a son with the same name. This decision therefore refers to the father as Dr. Harris. That reference is sadly also confusing, because one of the plaintiffs is Dr. Timothy J. Harris. This decision refers to him as Tim Harris.

2 B. Dr. Harris’s Illness

In October 2013, Dr. Harris was diagnosed with an aggressive form of aphasia

consistent with Alzheimer’s disease. As Dr. Harris’s health deteriorated, Judith Lolli

insinuated herself into Mary Ellen’s financial life.

Lolli brought Mary Ellen into contact with her own friends and advisors. Paul

Petigrow is a New Jersey lawyer who served as Lolli’s personal counsel. Charles Grinnell

is a New Jersey lawyer and career prosecutor who investigated and prosecuted the

gangland murder of Lolli’s brother, then became her close friend. Michael Schwager is

Lolli’s personal accountant and another close friend. Like the Complaint, this decision

refers to Lolli, Petigrow, Grinnell, and Schwager collectively as the “Advisors.”

C. The Takeover

With Dr. Harris’s health declining, questions arose as to who would lead the

Company. Mary Ellen had no experience or qualifications for the role. The eldest Sibling,

Robert M. Harris, Jr., had worked at the Company since 2000, held the office of Vice

President, and managed the relationship that generated the Company’s royalty stream.

A power struggle ensued with Mary Ellen and the Advisors on the one side and

Robert on the other. In April 2015, eighteen months after his Alzheimer’s diagnosis, Dr.

Harris purportedly acted by written consent to remove Robert from his position as an

officer.3 The written consent added Mary Ellen to the board of directors (the “Board”),

3 The Complaint alleges that Robert also signed a letter of resignation. In any event, he was out.

3 where Dr. Harris had been the sole director. The plaintiffs assert that Dr. Harris did not

have the capacity to execute the written consent and that Lolli pulled the strings so that

Mary Ellen gained control over the Company.

Immediately after the first consent, Dr. Harris and Mary Ellen executed a second

consent that caused the Company to enter into “an agreement with Lolli in substantially

the form submitted hereto.” Compl. ¶ 32. The consent did not attach an agreement. In

June 2015, Lolli and Mary Ellen executed an employment agreement which provided for

Lolli’s compensation to be determined at an unspecified future date. The Company began

providing Lolli with benefits and paying her $15,000 as an employee. The Company

retained Grinnell as a consultant at a rate of $110 per hour. Petigrow began doing legal

work for the Company. Schwager took over as the Company’s accountant. The Advisors

had gotten their noses inside the tent.

In late summer 2015, Lolli and Grinnell decided to form Royce Management, Inc.

Free access — add to your briefcase to read the full text and ask questions with AI

Timothy J. Harris v. Mary Ellen Harris, (Del. Ct. App. 2023).

Timothy J. Harris v. Mary Ellen Harris (Timothy J. Harris v. Mary Ellen Harris) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

CTS Corp. v. Dynamics Corp. of America
481 U.S. 69 (Supreme Court, 1987)
Parnes v. Bally Entertainment Corp.
722 A.2d 1243 (Supreme Court of Delaware, 1999)
Warburg, Pincus Ventures, L.P. v. Schrapper
774 A.2d 264 (Supreme Court of Delaware, 2001)
Ryan v. Gifford
918 A.2d 341 (Court of Chancery of Delaware, 2007)
Sternberg v. O'NEIL
550 A.2d 1105 (Supreme Court of Delaware, 1988)
NACCO INDUSTRIES, INC. v. Applica Inc.
997 A.2d 1 (Court of Chancery of Delaware, 2009)
Ison v. EI DuPont De Nemours and Co.
729 A.2d 832 (Supreme Court of Delaware, 1999)
McWane Cast Iron Pipe Corp. v. McDowell-Wellman Engineering Co.
263 A.2d 281 (Supreme Court of Delaware, 1970)
General Foods Corporation v. Cryo-Maid, Inc.
198 A.2d 681 (Supreme Court of Delaware, 1964)
Aveta, Inc. v. Colon
942 A.2d 603 (Court of Chancery of Delaware, 2008)
Hamilton Partners, L.P. v. Englard
11 A.3d 1180 (Court of Chancery of Delaware, 2010)
Gramercy Emerging Markets Fund v. Allied Irish Banks, P.L.C.
173 A.3d 1033 (Supreme Court of Delaware, 2017)
In re Primedia, Inc. Shareholders Litigation
67 A.3d 455 (Court of Chancery of Delaware, 2013)
In re Peierls Family Inter Vivos Trusts
77 A.3d 249 (Supreme Court of Delaware, 2013)
Martinez v. E.i. Dupont De Nemours & Co.
86 A.3d 1102 (Supreme Court of Delaware, 2014)
Hall v. Maritek Corp.
170 A.3d 149 (Superior Court of Delaware, 2017)
Aranda v. Philip Morris U.S. Inc.
183 A.3d 1245 (Supreme Court of Delaware, 2018)
Accord Healthcare, Inc. v. UCB, Inc.
139 S. Ct. 574 (Supreme Court, 2018)